Author

Y. Aliyazıcıoğlu

h-index 24 View on Semantic Scholar

We have 3 of 122 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Ferulic acid abrogates methotrexate-induced pulmonary injury by reducing inflammation and endoplasmic reticulum stress in rats.

Background The methotrexate (MTX) is employed in the treatment of various malignancies, including breast cancer and lymphoma, as well as chronic inflammatory diseases, but high doses can cause pulmonotoxicity. Ferulic acid (FEA) is a phenolic compound that has become a promising candidate for oxidative stress (OS) rela...

Nihal Turkmen Alemdar, Selim Demir, E. Yuluğ et al. · Physiology International · 0 citations

Open access Sep 2026

Candidate Regulatory Relationship and Expression Correlation Between miR-33a-5p and ANK3 in Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a type of bone marrow cancer characterized by the uncontrolled proliferation of myeloid cells. MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in the post-transcriptional regulation of gene expression. This study aims to examine the association between m...

Nurgul Kar, Sema Mısır, Serap Ozer Yaman et al. · Current Issues in Molecular... · 0 citations

Open access Jul 2026

Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation.

Findings have demonstrated NCX1 as a biologically informative marker of myeloid differentiation and a promising therapeutic weak point within calcium signaling networks in hematological malignancies, providing a rationale for future functional and single-cell validation studies.

Sema Mısır, S. Yaman, Nina Petrović et al. · Biochemical and Biophysical... · 0 citations